Murae Organisor Stock Hits All-Time Low Amidst Prolonged Downtrend

2 hours ago
share
Share Via
Murae Organisor, a company operating within the Pharmaceuticals & Biotechnology sector, has reached a new all-time low price of Rs.0.25, marking a significant milestone in its extended period of price decline. This development reflects a sustained downward trajectory over multiple time frames despite some recent positive financial disclosures.



Price Movement and Market Context


On 17 Dec 2025, Murae Organisor’s stock price touched Rs.0.25, setting a fresh 52-week and all-time low. The stock’s performance today showed a 4.00% gain, outperforming the broader sector by 4.06%, and the Sensex benchmark which moved by 0.21%. However, this short-term uptick contrasts with the longer-term trend where the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent downward pressure.


Examining the stock’s performance over various periods highlights the severity of its decline. Over the past week, the stock price remained flat, while the Sensex recorded a 0.55% rise. The one-month period saw a 13.33% reduction in Murae Organisor’s share price, compared to a marginal 0.11% dip in the Sensex. More notably, the three-month performance shows a 64.38% fall against a 2.61% gain in the Sensex. The year-long view reveals a stark contrast: Murae Organisor’s stock price declined by 87.68%, whereas the Sensex appreciated by 5.17%. Year-to-date figures mirror this trend with an 87.44% drop for the stock versus an 8.59% rise for the benchmark. Over three and five years, the stock’s value has contracted by approximately 87.53% and 96.41% respectively, while the Sensex has expanded by 38.34% and 80.96% in the same periods. The ten-year performance shows no change in the stock price, contrasting with a 228.85% increase in the Sensex.



Financial Metrics and Company Fundamentals


Murae Organisor’s financial indicators present a mixed picture. The company’s average Return on Equity (ROE) stands at 0%, indicating limited profitability relative to shareholder equity over the long term. The Debt to EBITDA ratio is notably high at 8.43 times, suggesting a considerable debt burden relative to earnings before interest, tax, depreciation, and amortisation. This ratio points to challenges in servicing debt obligations efficiently.


Conversely, recent quarterly results have shown growth in net profit and sales. The net profit growth rate is recorded at 161.05%, with the company declaring positive results for four consecutive quarters. Net sales for the latest six months reached Rs.519.52 crores, reflecting a growth rate of 225,778.26%. The quarterly profit after tax (PAT) was Rs.7.44 crores, representing a 295.7% increase compared to the previous four-quarter average. Earnings per share (EPS) for the quarter peaked at Rs.0.07.


Return on Capital Employed (ROCE) is measured at 0.4, and the Enterprise Value to Capital Employed ratio stands at 0.6, indicating a valuation that is comparatively attractive relative to capital utilisation. The stock is trading at a discount when compared to the average historical valuations of its peers within the Pharmaceuticals & Biotechnology sector.




Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.



  • - Investment Committee approved

  • - 50+ candidates screened

  • - Strong post-announcement performance


See Why It Was Chosen →




Shareholding and Sectoral Position


The majority of Murae Organisor’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The company operates within the Pharmaceuticals & Biotechnology sector, a space that has generally experienced growth and innovation, as reflected in the sector’s outperformance relative to the stock’s trajectory.


Despite the company’s recent positive profit growth and sales expansion, the stock’s valuation and price performance remain subdued. The divergence between improving earnings and declining share price suggests that market participants may be weighing other factors, including the company’s debt levels and historical price trends.




Considering Murae Organisor ? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this small-cap with top-rated alternatives now!



  • - Better options discovered

  • - Pharmaceuticals & Biotechnology + beyond scope

  • - Top-rated alternatives ready


Compare & Switch Now →




Summary of Performance Trends


Over the medium to long term, Murae Organisor’s stock has experienced a pronounced decline, with losses exceeding 85% over one, three, and five-year periods. This contrasts sharply with the broader market benchmark, the Sensex, which has recorded positive returns over the same intervals. The stock’s recent trading below all major moving averages further emphasises the prevailing downward momentum.


Financially, while the company has demonstrated growth in net sales and profits in recent quarters, its ability to generate returns on equity remains limited, and its debt servicing capacity is constrained by a high leverage ratio. The valuation metrics suggest the stock is priced at a discount relative to sector peers, reflecting the market’s cautious stance.


In conclusion, Murae Organisor’s stock price reaching an all-time low underscores the challenges faced by the company in aligning market valuation with its financial performance. The divergence between improving earnings and persistent price weakness highlights the complex factors influencing investor sentiment and stock valuation within the Pharmaceuticals & Biotechnology sector.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News